- Home
- NSPR
NSPR
InspireMD Inc.
as of 02-02-2026 3:48pm EST
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 67.4M | IPO Year: | N/A |
| Target Price: | $4.00 | AVG Volume (30 days): | 35.3K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.51 - $3.80 | Next Earning Date: | 03-11-2026 |
| Revenue: | $7,779,000 | Revenue Growth: | 14.04% |
| Revenue Growth (this year): | 22.76% | Revenue Growth (next year): | 75.45% |
AI-Powered NSPR Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of InspireMD Inc. (NSPR)
Chief Commercial Officer
Avg Cost/Share
$1.60
Shares
2,000
Total Value
$3,208.00
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.63
Shares
2,900
Total Value
$4,729.90
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.65
Shares
5,000
Total Value
$8,250.00
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.65
Shares
12,395
Total Value
$20,464.15
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.66
Shares
4,781
Total Value
$7,955.58
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.57
Shares
8,411
Total Value
$13,238.91
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.62
Shares
17,593
Total Value
$28,553.44
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.59
Shares
2,955
Total Value
$4,710.27
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.61
Shares
2,250
Total Value
$3,627.00
Owned After
1,139,177
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.58
Shares
2,909
Total Value
$4,593.31
Owned After
1,139,177
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Feb 2, 2026 | Sell | $1.60 | 2,000 | $3,208.00 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 30, 2026 | Sell | $1.63 | 2,900 | $4,729.90 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 29, 2026 | Sell | $1.65 | 5,000 | $8,250.00 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 28, 2026 | Sell | $1.65 | 12,395 | $20,464.15 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 27, 2026 | Sell | $1.66 | 4,781 | $7,955.58 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 22, 2026 | Sell | $1.57 | 8,411 | $13,238.91 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 21, 2026 | Sell | $1.62 | 17,593 | $28,553.44 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 20, 2026 | Sell | $1.59 | 2,955 | $4,710.27 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 16, 2026 | Sell | $1.61 | 2,250 | $3,627.00 | 1,139,177 | |
| Gleason Shane Thomas | NSPR | Chief Commercial Officer | Jan 15, 2026 | Sell | $1.58 | 2,909 | $4,593.31 | 1,139,177 |
Compare NSPR vs Leading Stocks
See how NSPR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NSPR InspireMD Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.